Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function

NCT06655441 is registered in ClinicalTrials.gov with Southern California College of Optometry at Marshall B. Ketchum University as lead sponsor.

NCT NCT06655441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06655441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function
Lead sponsor
Southern California College of Optometry at Marshall B. Ketchum University
Phase
Phase 4
Overall status
Recruiting
Start date
March 1, 2026
Completion date
April 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease (ded)